Metastatic castration-resistant prostate is an advanced form of the cancer that’s incurable. Learn about treatment options ...

Metastatic castration-resistant prostate cancer (mCRPC) treatment can involves chemotherapy, radiation, and more. Find the ...

Prostate cancer is one of the most frequently diagnosed cancers in men. Prostate tumor staging and disease aggressiveness are evaluated based on the Gleason scoring system, which is further used to ...

It is well known that men are reluctant to see a doctor, especially a urologist. As a result, there is a risk that prostate ...

Prostate cancer that has spread to other parts of the body has limited treatment options, but a biomedical research group affiliated with Main Line Health has begun investigating a new therapy for ...

New research from the Centenary Institute has found that switching off a specific protein in liver cells may help prevent the early development of liver cancer. More than 3,000 people are ...

Exercise 3 days per week improved sexual function for men with prostate cancer vs. usual care. Exercise also improved fat mass and muscle strength. Exercise improved erectile dysfunction compared ...

MPs campaigning for a national prostate cancer testing rollout admitted they were 'embarrassed' to have put off getting checked themselves - despite being in the most at-risk group. Former Home ...

Good Health recently reported how the programme, the first to combine prostate-specific antigen (PSA) blood tests (to measure levels of a protein in the blood that can rise when cancer is present ...

PSA is a protein produced by the prostate gland. A high PSA level does not mean you have cancer but is a warning sign which can then lead to further scans and tests to rule out the disease.

An assay based on gold nanoparticles could detect recurrences of prostate cancer sooner than is possible with existing techniques. For over 20 years the success of surgery to treat prostate cancer ...

better engaging with CD36 to internalize these drugs to more efficiently reach the target protein.” Several companies are developing PROTACs to treat cancer, neurodegenerative diseases like ...